GeneralConnection.com ➔ Dictionary
Dictionary Search

inhibitor

Synonyms

Noun

1. substance

2. matter

Usage
The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond - Nature
Denecimig (Mim8) significantly reduced annualized bleeding rate in people with hemophilia A, regardless of inhibitor status, in phase 3 data published in NEJM - PR Newswire
AstraZeneca scraps FLAP inhibitor after flunking phase 2 asthma trial - Fierce Biotech
AbbVie throws its hat into the RAS ring - FirstWord Pharma
Dear Doctor: If I stop taking proton-pump inhibitors, will I see a ‘rebound effect,’ return of stomach proble - OregonLive.com
Combining a PCNA Inhibitor with KRAS-Targeting Agents in PDAC - CancerNetwork
Coultreon lands $125m to push SIK inhibitor into mid-stage trials - The Pharma Letter
Kestrel Therapeutics Announces First Patient Dosed in the - GlobeNewswire
Lilly announces a new cancer deal, paying Ajax up to $2.3B for JAK inhibitor - Endpoints News
Incyte’s JAK inhibitor scores phase 3 vitiligo wins but can’t quite shake off Rinvoq - Fierce Biotech
Appendectomy or JAK inhibitor in Active UC; Upadacitinib Benefit–Risk Profile - Gastroenterology & Endoscopy News
Acrobat Genomics Advances to Next Phase of AI-Powered Inhibitor Discovery Program - CRISPR Medicine News
RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer - The ASCO Post
Optimal HR+ Early Breast Cancer Care Must Weigh CDK4/6 Inhibitor Efficacy With Adherence - OncLive
Experimental Drug Suppressed Gut and Systemic Gluten Responses in Coeliac Disease - Technology Networks
Stephen V Liu: Next Gen ROS1 Inhibitor Cancer Cell Look Promising After Phase I Results for JYP0322 - Oncodaily
Promising New KRAS Inhibitor Trial Doses Its First Patient - The Clinical Trial Vanguard
Study suggests how to predict which cancer patients will benefit from ATR inhibitors - Duke University School of Medicine
Lilly maintains M&A hot streak with $2.3B deal for next-gen JAK inhibitor biotech Ajax - Fierce Biotech
Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies - Nature
D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types - PR Newswire
Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma - CancerNetwork
Complement inhibition by a unique cluster of immunomodulatory outer surface proteins of Borrelia recurrentis - Nature
AbbVie dips into boiling RAS waters with $1.45B biobucks deal that could end in acquisition - Fierce Biotech
Inhibition of angiogenesis by propranolol in infantile hemangiomas via lncRNA NEAT1-mediated miR-194-5p/TRAF6/NF-κB pathway - Nature
IL-17 Inhibition and Long-Term Outcomes in Psoriasis - HCPLive
Comprehensive profiling of clinically approved kinase inhibitors reveals mutation-specific inhibitors and opportunities for drug repurposing - Nature
Upadacitinib After TNF Inhibitor Failure Improves RA Control - Medscape
Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer - Medical Xpress
Initial Data Shows Safety for WEE1 PKMYT1 Inhibitor Combination in Advanced Solid Tumors - The ASCO Post
Lilly adds potential first-in-class Type II JAK2 inhibitor to haematology portfolio - European Pharmaceutical Review
Stopping RAS Inhibitors Linked to Worse CKD Outcomes - Medscape
Coultreon Raises $125m To Take Lead SIK3 Inhibitor Into Phase II - Citeline News & Insights
Oruka Therapeutics: 'Strong Buy' On Half-Life Extended IL-23p19 Inhibitor ORKA-001 - Seeking Alpha
Covalent inhibitor design confers activity against both GDP- and GTP-bound forms of KRAS G12C - Nature
Clinical Guidance for Managing Meningococcal Disease Risk in Patients Receiving Complement Inhibitor Therapy - Centers for Disease Control and Prevention | CDC (.gov)
Aldose reductase inhibition suppresses microglial endoplasmic reticulum stress and ferritinophagy in ischemic stroke - Nature
A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide - New England Journal of Medicine
CGRP Inhibitors Market Size Set for Significant Growth by 2033, According to Persistence Market Research - openPR.com
145 Racial Differences in Outcomes and Health Care Utilization Among Patients With HR-Positive, HER2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Real-World Analysis - CancerNetwork
AbbVie sinks talons into KRAS with right to buy Kestrel for up to $1.45B - BioSpace
FDA Staff Raises Concerns on Breast, Prostate Cancer Drug Applications - MedPage Today
New cGAS inhibitors reported in Riltide Medicines patent - BioWorld News
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics - Pharmaceutical Executive
Meningococcal Disease and People Receiving Complement Inhibitors - Centers for Disease Control and Prevention | CDC (.gov)
Shanghai Yingli Pharmaceutical synthesizes new OGG1 inhibitors - BioWorld News
Foshan Ionova Biotherapeutics identifies new IL-17A inhibitors - BioWorld News
Pharmacokinetics, pathology and efficacy of SARS-CoV-2 main protease inhibitor VPC285785 in a murine model of coronavirus infection - Nature
Roswell Park experts explore wider use of CDK inhibitor therapy - Buffalo News
RINVOQ® Demonstrated Superiority Versus HUMIRA® for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor - Investing News Network
Galapagos spinout Coultreon raises $125M for new take on SIK inhibition - Endpoints News
Vascular Endothelial Growth Factor Inhibitors Market to Reach USD 33.5 Billion by 2036, Driven by Rising Cancer Burden, Biosimilar Expansion, and Shift Toward Subcutaneous Therapies - PR Newswire
Targeting plasminogen activator inhibitor 1 for cancer and longevity - Nature
Emerging Role of Oral JAK Inhibition in Vitiligo Management - Managed Healthcare Executive
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera - Investing News Network
FDA Approves Revumenib, a Menin Inhibitor, for Aggressive Leukemia - Memorial Sloan Kettering Cancer Center
Aclaris Therapeutics to Provide Clinical Update on Key Biologic and Oral Inhibitor Programs on April 28, 2026 - GlobeNewswire
Inhibitors supercharge kinase turnover through native proteolytic circuits - Nature
In silico discovery of natural compound-derived multi-target inhibitor for Huntington’s disease therapy - Nature
Aclaris Therapeutics Announces Positive Full Top Line First-in-Human Results from Phase 1a Healthy Volunteer Clinical Trial of ATI-052, a Novel Potential First-in-Class Anti-TSLP/IL-4Rα Bispecific Antibody, and Announces Lichen Planus as Lead Indication f - Yahoo Finance Australia
STAT Inhibitors Pipeline Set for Breakthrough Innovation - openPR.com
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition - TradingView
TGM2-mediated serotonylation of GPX4 confers ferroptosis resistance to promote gastric tumorigenesis - Nature
The Latest on Prostate Cancer Checkpoint Inhibitor Immunotherapy at MSK - Memorial Sloan Kettering Cancer Center
What Aclaris will reveal Tuesday on two immune-disease drug programs - Stock Titan
Eli Lilly and Company to Acquire Ajax Therapeutics to Advance JAK2 Inhibition - Oncodaily
Discovery of hydroxytriazole as a potential glyoxalase-I inhibitor utilizing computer-aided drug design techniques - Nature
Gilead Sciences reports new GTPase KRAS G12D inhibitors and degraders - BioWorld News
Onco-Innovations Announces Successful Scale-Up of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for its PNKP Inhibitor Technology Program - ACCESS Newswire
Discovery of potent and selective inhibitors of human NLRP3 with a novel mechanism of action - Rockefeller University Press
Corrosion Inhibitors Market: Asia Leads Growth as Ecolab, BASF, Nouryon Drive 2036 Outlook - openPR.com
/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo - Nature
Vanillin as eco-friendly corrosion inhibitor for aluminum immersed in 0.5 M H2SO4 | Scientific Reports - Nature
Weight-Loss Injections, Cancer Cell Inhibitors & the Power of Algorithms: Adding Potential to Your Portfolio with Novo Nordisk, Vidac Pharma, and Evotec - news.financial
ADAM17 as a promising therapeutic target: from structural basis to inhibitor discovery in human diseases - Frontiers
Optimizing enzyme inhibition analysis: precise estimation with a single inhibitor concentration - Nature
Proton pump inhibitor use is not independently associated with colonic diverticulosis in an asymptomatic screening population - Nature
Analysis of the ACE Inhibitors Market: Industry Structure, Emerging Trends, and Key Player Overview - openPR.com
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol - AJMC
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial - Nature
Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2 - Science | AAAS
Helicobacter pylori CagA protein is a potent and broad-spectrum amyloid inhibitor - Science | AAAS
Serine protease inhibitor dipetalogastin-like from Galleria mellonella is involved in insect immunity - Nature
From Concepts to Inhibitors: A Blueprint for Targeting Protein–Protein Interactions | Chemical Reviews - ACS Publications
HIF2α Inhibitors: New Frontiers in Cancer Treatment - Bioengineer.org
Structural characterization of the urea transporter bound to the orally bioavailable inhibitor E3 - Nature
RINVOQ® (upadacitinib) Demonstrated Superiority Versus HUMIRA® (adalimumab) for Primary Endpoint in a Head-to-Head Study in Rheumatoid Arthritis Patients Who Have Failed First TNF inhibitor - The Malaysian Reserve
HDAC inhibitor GCJ-490A modulates tumor microenvironment and synergizes with PD-1 antibody against breast and lung cancers in syngeneic murine models - Nature
Inhibition of epithelial cell YAP-TEAD/LOX signaling attenuates pulmonary fibrosis in preclinical models - Nature
Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects - Nature
Cuminum cyminum as green corrosion inhibitor for API 5 L X70 carbon steel in 0.5 M H2SO4 solution | Scientific Reports - Nature
Cyclic peptide inhibitors function as molecular glues to stabilize Gq/11 heterotrimers - PNAS
Accelerating drug target inhibitor discovery with a deep generative foundation model - Science | AAAS
Assessment of Hsp90β-selective inhibitor safety and on-target effects - Nature
What are PARP inhibitors? - UT MD Anderson
AACR: First-in-class covalent Werner helicase inhibitor shows clinical proof-of-concept in Phase I trial - UT MD Anderson
An allosteric inhibitor of RhoGAP class-IX myosins suppresses the metastatic features of cancer cells - Nature
A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity - Nature
A structure-based framework for selective inhibitor design and optimization - Nature
Ibetazol, a novel inhibitor of importin β1-mediated nuclear import - Nature
Foreign Language Equivalents
Foreign Language Equivalents of 'inhibitor'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
inhibutor,   inhiibitor,   onhibitor,   inhivitor,   inhhibitor,   ibhibitor,   inhibitir,   inhibior,   inhibiyor,   ingibitor,   inhibtior,   nhibitor,   inhibito,   imhibitor,   inhibittor,   inhiibtor,   inhibtor,   ihibitor,   iinhibitor,   inhibitoe,   inhbiitor,   ihnibitor,   injibitor,   inhibbitor,   unhibitor,   inhibiter,   inhibiror,   inhobitor,   inhubitor,   inhiitor,   inhinitor,   nihibitor,   inhibotor,   inhbitor,   inhibiotr,   inhibitorr,   inhibitoor,   inhibiitor,   inhibitot,   inhibitpr,   inhibitro,   innhibitor,   inhibitr,   inihbitor,   inibitor
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z